Evidence map›Paper›PMID 24516231›Full record

Observational studyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2014

DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.

Maria R Wing, Joseph M Devaney, Marshall M Joffe, Dawei Xie, Harold I Feldman, Elizabeth A Dominic, Nicolas J Guzman, Ali Ramezani, Katalin Susztak, James G Herman and 10 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 2 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The AKI-to-CKD Transition: The Role of Uremic Toxins.International journal of molecular sciences · 2023
    Review
  20. Sex-specific epigenetic programming in renal fibrosis and inflammation.American journal of physiology. Renal physiology · 2023
    Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

Maria R WingDivision of Renal Diseases and Hypertension, The George Washington University School of Medicine, Washington, DC, USA.
Joseph M Devaney
Marshall M Joffe
Dawei Xie
Harold I Feldman
Elizabeth A Dominic
Nicolas J Guzman
Ali Ramezani
Katalin Susztak
James G Herman
Leslie Cope
Brennan Harmon
Bernard Kwabi-Addo
Heather Gordish-Dressman
Alan S Go
Jiang He
James P Lash
John W Kusek
Dominic S Raj
Chronic Renal Insufficiency Cohort (CRIC) Study
George Washington University · USUniversity of Pennsylvania · USChildren's National · USAlbert Einstein College of Medicine · USHoward University · USJohns Hopkins University · USKaiser Permanente · USNational Institutes of Health · USSidney Kimmel Comprehensive Cancer Center · USTulane University · USUniversity of Illinois Chicago · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENFIRE, MELVYN · 1985 to 2007
$40.8M
Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI OSWALD, LYNN M · 2002 to 2009
$20.2M
Study of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5M
ZENARESTAT IN DIABETIC NEUROPATHYM01RR005096 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI FONSECA, VIVIAN A · 1990 to 2006
$17.4M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR000439NCRR NIH HHS M01 RR000042NCRR NIH HHS M01RR000042NCRR NIH HHS M01 RR005096NCRR NIH HHS M01 RR016500NCRR NIH HHS M01RR16500NCRR NIH HHS RR05096NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1RR024131NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1RR024134NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1RR024986NCRR NIH HHS UL1 RR024989NCRR NIH HHS UL1RR024989NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NCRR NIH HHS UL1 RR029879NCRR NIH HHS UL1RR029879NIDDK NIH HHS 1U01DK099914-01NIDDK NIH HHS 1U01DK099924-01NIDDK NIH HHS 5U01DK060902NIDDK NIH HHS 5U01DK060963NIDDK NIH HHS 5U01DK060984NIDDK NIH HHS 5U01DK060990NIDDK NIH HHS 5U01DK06102NIDDK NIH HHS 5U01DK061021NIDDK NIH HHS 5U01DK061028NIDDK NIH HHS 5U01DK60980NIDDK NIH HHS DP3 DK108220NIDDK NIH HHS R01 DK073665NIDDK NIH HHS R01 DK073665-01A1NIDDK NIH HHS R01 DK087635NIDDK NIH HHS R01 DK139225NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061021NIDDK NIH HHS U01 DK061028NIDDK NIH HHS U01 DK099914NIDDK NIH HHS U01 DK099924
6 · The paper itself

Abstract

backgroundEpigenetic mechanisms may be important in the progression of chronic kidney disease (CKD).

methodsWe studied the genome-wide DNA methylation pattern associated with rapid loss of kidney function using the Infinium HumanMethylation 450 K BeadChip in 40 Chronic Renal Insufficiency (CRIC) study participants (n = 3939) with the highest and lowest rates of decline in estimated glomerular filtration rate.

resultsThe mean eGFR slope was 2.2 (1.4) and -5.1 (1.2) mL/min/1.73 m(2) in the stable kidney function group and the rapid progression group, respectively. CpG islands in NPHP4, IQSEC1 and TCF3 were hypermethylated to a larger extent in subjects with stable kidney function (P-values of 7.8E-05 to 9.5E-05). These genes are involved in pathways known to promote the epithelial to mesenchymal transition and renal fibrosis. Other CKD-related genes that were differentially methylated are NOS3, NFKBIL2, CLU, NFKBIB, TGFB3 and TGFBI, which are involved in oxidative stress and inflammatory pathways (P-values of 4.5E-03 to 0.046). Pathway analysis using Ingenuity Pathway Analysis showed that gene networks related to cell signaling, carbohydrate metabolism and human behavior are epigenetically regulated in CKD.

conclusionsEpigenetic modifications may be important in determining the rate of loss of kidney function in patients with established CKD.

Indexed as

Epigenesis, GeneticGlomerular Filtration RateAdultAgedDisease ProgressionDNA MethylationEpithelial-Mesenchymal TransitionFemaleHumansMaleMiddle AgedPrognosisRenal Insufficiency, ChronicYoung Adultchronic renal diseasechronic renal disease progressionDNA methylationepigenetics

Identifiers

PMID24516231
PMCPMC3967834
OpenAlexW2105314711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.